Development of the Deoxycorticosterone Acetate (DOCA)-salt Hypertensive Rat Model.
Blood pressure
DOCA-salt
High salt diet
Neurogenic hypertension
Sympathetic nervous system
Journal
Bio-protocol
ISSN: 2331-8325
Titre abrégé: Bio Protoc
Pays: United States
ID NLM: 101635102
Informations de publication
Date de publication:
05 Aug 2020
05 Aug 2020
Historique:
received:
31
12
2019
revised:
25
05
2020
accepted:
10
06
2020
entrez:
4
3
2021
pubmed:
5
3
2021
medline:
5
3
2021
Statut:
epublish
Résumé
According to the World Health Organization (WHO), nearly 1.13 billion people worldwide have hypertension, a major factor responsible for premature death globally. The inherent multifactorial nature of hypertension makes its study difficult since the chronic rise in blood pressure depends on the intricate connection between dietary, genetic and environmental factors. Therefore, the pathophysi-ology of hypertension is not completely understood. For these reasons, there is an ongoing search for animal models that better mimic changes resulting from this disease. Because of its complexity, the use of animal models aimed at elucidating the pathogenesis of hypertension and to evaluate new therapeutic possibilities is an important tool for understanding this disease since it enables consistent experimental strategies that are impractical in humans. Over time, many animal models have been developed for the study of chronic increases in blood pressure ranging from genetic models that include the spontaneously hypertensive rat (SHR) and genetic manipulations, such as the TGR (mRen2) rat, as well as neurogenic or endocrine models. One of the most commonly used hypertensive rat models today is that of hypertension induced by treatment with deoxycorticosterone acetate associated with high sodium intake,
Identifiants
pubmed: 33659372
doi: 10.21769/BioProtoc.3708
pii: e3708
pmc: PMC7842531
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e3708Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL064178
Pays : United States
Informations de copyright
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare no conflicts of interest (financial or any otherwise) involved in this article.
Références
Am J Physiol. 1989 Jan;256(1 Pt 2):R138-45
pubmed: 2912206
Am J Physiol. 1999 Jun;276(6 Pt 2):S79-85
pubmed: 16211671
Compr Physiol. 2012 Oct;2(4):2393-442
pubmed: 23720252
Hypertension. 2011 Mar;57(3):600-7
pubmed: 21263123
Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H1965-73
pubmed: 21890693
Brain Res. 2006 Sep 13;1109(1):74-82
pubmed: 16859651
Methods Mol Biol. 2009;573:57-73
pubmed: 19763922
Hypertension. 2019 Jun;73(6):e87-e120
pubmed: 30866654
Curr Protoc Mouse Biol. 2011;1:105-122
pubmed: 21686061
J Vis Exp. 2011 Nov 21;(57):
pubmed: 22126906
Am J Physiol Regul Integr Comp Physiol. 2018 Sep 1;315(3):R568-R575
pubmed: 29897819
Curr Hypertens Rep. 2017 Apr;19(4):32
pubmed: 28353076